DDD vs DROR vs PAIYY Stock Comparison

3D Systems, Dror Ortho-Design and Aesthetic Medical International Holdings Prices as of Oct 26, 2026 Peers: Industry group
DDD 3D Systems Corp
$2.95 -17.4% 1M -5.8% 1Y
Market cap
$450.63M
P/E
–
Revenue (TTM)
$387.64M
Div. yield
–
3D Printing Industrials
3 wins

Head to Head

6 decided of 12

3D Systems leads on 3 of the 12 questions below (3D Systems 3, Dror Ortho-Design 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionDDDDRORPAIYYLeader
Larger companyMarket capitalisation $450.63M $9.77M $491.09K DDD
Cheaper on earningsLower P/E, profitable companies only -8.2x -4.0x -0.1x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — — –
Faster revenue growthRevenue growth, trailing twelve months -6.2% — — –
More profitableNet margin, trailing twelve months -14.2% — — –
Better return on capitalReturn on invested capital -17.8% — — –
Less leveragedLower net debt / EBITDA 1.0x -1.3x — DROR
Higher dividend yieldTrailing dividend yield 0.00% — — –
Better 1-year returnPrice return, last 12 months -5.8% 0.0% -95.2% DROR
Better 5-year returnAnnualised price return, 5 years -35.8%/yr -35.6%/yr -70.1%/yr DROR
Less volatileAnnualised volatility, 1 year 84.2% 320.7% 421.9% DDD
Higher overall scoreMean of the five percentile scores vs peers 31/100 26/100 — DDD

Percentile Scorecard

DDDDRORPAIYY

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisDDDDRORPAIYY
Valuation 16 #170 of 203 16 #192 of 228 22 #73 of 93
Growth 59 #78 of 187 62 #84 of 221 –
Profitability 11 #164 of 185 – –
Financial Health 65 #78 of 219 1 #237 of 239 11 #89 of 100
Shareholder Returns 5 #145 of 153 – –
Overall 31 26 –
  • DDD ranked among 222 companies in Machinery
  • DROR ranked among 248 companies in Medical Devices and Diagnostics
  • PAIYY ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodDDDDRORPAIYYSPY
1 month -17.4%0.0%-50.0% -0.8%
3 months +12.2%0.0%-50.0% +3.5%
6 months +33.5%0.0%-88.9% +7.0%
Year to date +66.7%0.0%-94.1% +12.2%
1 year -5.8%0.0%-95.2% +13.0%
3 years -17.1%-50.0%-98.4% +86.3%
3 years, per year -6.1%-20.6%-74.9% +23.1%
5 years -89.1%-88.9%-99.8% +68.6%
5 years, per year -35.8%-35.6%-70.1% +11.0%
10 years -79.3%—— +258.0%
10 years, per year -14.6%—— +13.6%

Risk

MeasureDDDDRORPAIYYSPY
Volatility, 1Y 84.2%320.7%421.9% 12.7%
Downside volatility, 1Y 75.4%1,199.8%1,222.1% 12.7%
Beta vs S&P 500, 1Y 2.820.13-3.71 1.00
Return / volatility, 1Y -0.070.00-0.23 1.02
Max drawdown, 5Y -96.0%-92.3%-99.8% -25.4%
From 52-week high -24.0%-66.7%-96.9% -1.8%
52-week high $3.88$0.03$0.32 $779.14
52-week low $1.77$0.01$0.01 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleDDDDRORPAIYY
P/E now vs peer median -8.0xmedian 26.0x -4.0xmedian 30.6x -0.1xmedian 25.1x
P/S now vs peer median 1.3xmedian 1.9x —median 3.0x 0.0xmedian 1.6x
EV/EBITDA now vs peer median -11.7xmedian 14.0x -8.4xmedian 17.5x —median 14.5x
P/FCF now vs peer median -9.4xmedian 21.4x -5.5xmedian 23.3x -0.2xmedian 22.4x
P/B now vs peer median 1.8xmedian 2.2x -2.5xmedian 2.4x -0.1xmedian 3.1x
PEG now vs peer median -0.30median 1.26 -0.12median 0.87 —median 0.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsDDDDRORPAIYY
Revenue $387.64M – –
Gross profit $131.01M – –
Operating income -$61.26M -$1.91M –
Net income -$54.85M -$2.47M –
Free cash flow -$52.40M -$1.78M –
R&D $47.60M $521.41K –
EPS (diluted) $-0.37 $0.00 –
Cash & equivalents $127.95M $93.56K $8.61M
Total debt $91.18M $5.57M $76.21M
Shares (diluted) 148.97M 977.00M 47.83M
Enterprise value $46.42M $9.18M -$24.51M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricDDDDRORPAIYY
P/E -8.0x -4.0x -0.1x
P/FCF -9.4x -5.5x -0.2x
P/Operating cash flow -11.6x -5.5x –
P/S 1.3x – 0.0x
P/B 1.8x -2.5x -0.1x
P/Tangible book 1.9x -2.5x -0.1x
EV/EBITDA -11.7x -8.4x –
EV/EBIT -7.4x -6.1x –
EV/Revenue 1.2x – –
EV/FCF -8.7x -6.5x –
EV/Operating cash flow -10.7x -6.5x –
PEG (3Y EPS CAGR) -0.30 -0.12 –

Growth

14 metrics
MetricDDDDRORPAIYY
Revenue growth (1Y) -6.2% – –
Revenue CAGR (3Y) -9.0% – –
Gross profit growth (1Y) -9.6% – –
Gross profit CAGR (3Y) -13.8% – –
Operating income growth (1Y) 76.7% 49.0% –
Operating income CAGR (3Y) 21.6% -5.3% –
Net income growth (1Y) 62.1% 42.4% –
Net income CAGR (3Y) 23.3% -15.2% –
EPS growth (1Y) 53.6% 43.6% –
EPS CAGR (3Y) 26.7% 31.8% –
Operating cash flow growth (1Y) 38.0% 20.4% –
Operating cash flow CAGR (3Y) 18.5% 10.2% –
Free cash flow growth (1Y) 36.8% 20.4% –
Free cash flow CAGR (3Y) 20.0% 10.2% –

Profitability

14 metrics
MetricDDDDRORPAIYY
Gross margin 33.8% – –
EBITDA margin -10.0% – –
Operating margin -15.8% – –
Pretax margin -11.7% – –
Net margin -14.2% – –
FCF margin -13.5% – –
Operating cash flow margin -10.9% – –
Return on equity -21.7% – –
Return on assets -10.5% -798.5% –
Return on invested capital -17.8% – –
Return on capital employed -14.7% – –
Asset turnover 0.7x – –
Cash conversion (OCF / net income) 0.8x 0.7x –
Stock comp / revenue 3.5% – –

Financial Health

11 metrics
MetricDDDDRORPAIYY
Debt / assets 17.0% 512.4% 28.2%
Debt / equity 0.3x -0.5x -3.3x
Net debt / EBITDA 1.0x -1.3x –
Debt / FCF -1.7x -1.1x –
Liabilities / assets 48.9% 1,177% 108.5%
Equity / assets 51.1% -1,077% -8.5%
Interest coverage – – –
Current ratio 3.4x 0.1x –
Quick ratio 1.9x 0.0x 0.3x
Cash ratio 1.2x 0.0x 0.1x
Altman Z-score -1.48 – –

Shareholder Returns

7 metrics
MetricDDDDRORPAIYY
Dividend yield – – –
Net buyback yield -10.9% – –
Shareholder yield -10.9% – –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusDDDDRORPAIYY
EPS, next fiscal year $-0.14FY2026 – $-1.50FY2023
Revenue, next fiscal year $368.77MFY2026 – $89.98MFY2023
Revenue growth, next FY -4.7%FY2026 – –
Revenue growth, the year after +7.8% – –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersDDDDRORPAIYY
Held by institutions 71.1% – –
Institutions holding 210 – –
Change in shares held, QoQ +34.8% – –
Institutions buying 126 – –
Institutions selling 37 – –
Buyers to sellers 3.41 – –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

DDDDRORPAIYY
DDD 1.00 -0.10 -0.05
DROR -0.10 1.00 0.00
PAIYY -0.05 0.00 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, DDD, DROR and PAIYY?

3D Systems (DDD) is the largest by market capitalisation: 3D Systems (DDD) $450.63M, Dror Ortho-Design (DROR) $9.77M, Aesthetic Medical International Holdings (PAIYY) $491.09K.

Which stock has performed better?

Over the past year Dror Ortho-Design (DROR) returned the most: 3D Systems (DDD) -5.8%, Dror Ortho-Design (DROR) 0.0%, Aesthetic Medical International Holdings (PAIYY) -95.2%. Over five years, Dror Ortho-Design (DROR) compounded fastest (3D Systems (DDD) -35.8%/yr, Dror Ortho-Design (DROR) -35.6%/yr, Aesthetic Medical International Holdings (PAIYY) -70.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, 3D Systems (DDD) has been the steadiest (3D Systems (DDD) 84.2%, Dror Ortho-Design (DROR) 320.7%, Aesthetic Medical International Holdings (PAIYY) 421.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, DDD, DROR and PAIYY?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, 3D Systems (DDD) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.